SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 228 filers reported holding SAGE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,058 | -56.2% | 100 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $4,702 | +12.1% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $4,196 | +10.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $3,814 | -4.6% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $4,000 | +33.3% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $3,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | -25.0% | 100 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $4,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $4,000 | -33.3% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $6,000 | -14.3% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $7,000 | -22.2% | 100 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $9,000 | +50.0% | 100 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $6,000 | +50.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $4,000 | +33.3% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $3,000 | -57.1% | 100 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $7,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 5,149,482 | $105,976,340 | 2.24% |
| Palo Alto Investors LP | 1,005,776 | $20,698,870 | 1.96% |
| Boxer Capital, LLC | 1,094,000 | $22,514,520 | 1.20% |
| Bellevue Group AG | 3,513,351 | $72,304,764 | 1.16% |
| PDT Partners, LLC | 181,625 | $3,737,843 | 0.47% |
| EASTERLY INVESTMENT PARTNERS LLC | 195,643 | $4,026,333 | 0.44% |
| Harvest Investment Services, LLC | 30,302 | $623,615 | 0.40% |
| Simplify Asset Management Inc. | 120,030 | $2,470,217 | 0.28% |
| SAMLYN CAPITAL, LLC | 739,867 | $15,226,463 | 0.25% |
| CAXTON ASSOCIATES LP | 68,035 | $1,400,160 | 0.19% |